StockData
ANI Pharmaceuticals Inc logo

ANI Pharmaceuticals Inc (ANIP) stock

ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3048% below fair value
$69.99−0.90 (-1.27%)

Close on Nov 17, 2026Market cap $1.61BP/E 14.9Yield –

ANI Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

ANI Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was 11.1%. For fiscal 2025 it was 8.9%, against -3.0% the year before. The highest annual figure on record is 51.4% in fiscal 2014.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20258.9%+11.9
FY2024Dec 31, 2024-3.0%−6.9
FY2023Dec 31, 20233.9%+19.0
FY2022Dec 31, 2022-15.1%+4.6
FY2021Dec 31, 2021-19.7%−8.9
FY2020Dec 31, 2020-10.8%−13.8
FY2019Dec 31, 20193.0%−4.7
FY2018Dec 31, 20187.7%+8.3
FY2017Dec 31, 2017-0.6%−3.7
FY2016Dec 31, 20163.1%−17.1
FY2015Dec 31, 201520.1%−31.2
FY2014Dec 31, 201451.4%+50.4
FY2013Dec 31, 20131.0%+8.4
FY2012Dec 31, 2012-7.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 20269.3%+5.2
Q1 FY2026Mar 31, 202612.4%+4.5
Q4 FY2025Dec 31, 202511.1%+16.5
Q3 FY2025Sep 30, 202511.7%+28.0
Q2 FY2025Jun 30, 20254.0%+5.7
Q1 FY2025Mar 31, 20258.0%−5.3
Q4 FY2024Dec 31, 2024-5.4%−6.3
Q3 FY2024Sep 30, 2024-16.3%−23.8
Q2 FY2024Jun 30, 2024-1.7%−7.0
Q1 FY2024Mar 31, 202413.2%+11.9
Q4 FY2023Dec 31, 20230.9%+5.4
Q3 FY2023Sep 30, 20237.5%+17.8
Q2 FY2023Jun 30, 20235.4%+25.6
Q1 FY2023Mar 31, 20231.3%+32.6
Q4 FY2022Dec 31, 2022-4.5%+35.1
Q3 FY2022Sep 30, 2022-10.3%−1.7
Q2 FY2022Jun 30, 2022-20.2%+8.8
Q1 FY2022Mar 31, 2022-31.2%−31.4
Q4 FY2021Dec 31, 2021-39.6%−33.3
Q3 FY2021Sep 30, 2021-8.5%−9.4
Q2 FY2021Jun 30, 2021-29.0%−3.6
Q1 FY2021Mar 31, 20210.2%+14.2
Q4 FY2020Dec 31, 2020-6.3%+3.7
Q3 FY2020Sep 30, 20200.8%−6.8
Q2 FY2020Jun 30, 2020-25.5%−37.6
Q1 FY2020Mar 31, 2020-14.1%−14.9
Q4 FY2019Dec 31, 2019-10.1%−19.6
Q3 FY2019Sep 30, 20197.6%−2.3
Q2 FY2019Jun 30, 201912.1%+6.2
Q1 FY2019Mar 31, 20190.8%−4.0
Q4 FY2018Dec 31, 20189.5%+29.9
Q3 FY2018Sep 30, 20189.9%+0.1
Q2 FY2018Jun 30, 20185.9%−0.1
Q1 FY2018Mar 31, 20184.8%+1.7
Q4 FY2017Dec 31, 2017-20.4%−17.5
Q3 FY2017Sep 30, 20179.8%+3.2
Q2 FY2017Jun 30, 20176.0%–
Q1 FY2017Mar 31, 20173.1%–
Q4 FY2016Dec 31, 2016-2.8%–
Q3 FY2016Sep 30, 20166.6%–

More ANI Pharmaceuticals figures

See a number that looks wrong?